NCT06868004

Brief Summary

This clinical study aims to evaluate the effects of a holistic nursing (HN) intervention on cognitive function, psychological well-being, and overall health outcomes in patients with Alzheimer's disease (AD). AD is a progressive neurodegenerative disorder characterized by cognitive decline and behavioral changes, significantly impacting patients' quality of life and increasing the burden on caregivers. Conventional treatment primarily involves pharmacological interventions, but non-pharmacological approaches, such as specialized nursing care, have shown potential in improving patient outcomes. This study prospectively enrolled 105 AD patients admitted to our hospital between January 2023 and January 2024. Patients were divided into two groups based on admission periods: the control group (n=58) received standard care, while the observation group (n=47) received HN in addition to standard care. The HN intervention was implemented based on established guidelines for older adults with cognitive impairment and consisted of five key components: psychological support, cognitive stimulation, memory enhancement, self-care training, and environmental optimization. The study assessed cognitive function, psychiatric symptoms, anxiety, and depression levels before and after the intervention using validated scales, including the Mini-Mental State Examination (MMSE), Neuropsychiatric Inventory (NPI), Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-cog), Montreal Cognitive Assessment (MoCA), and Self-rating Anxiety/Depression Scales (SAS/SDS). Additionally, blood biomarkers related to neurological function, such as dopamine, acetylcholine, serotonin, γ-aminobutyric acid, S100β, homocysteine, and interleukin-1β, were measured. Patient compliance, safety outcomes, and family satisfaction with the nursing intervention were also evaluated. The findings of this study may provide evidence supporting the integration of HN as a complementary approach in AD management, potentially improving cognitive function, reducing psychiatric symptoms, and enhancing overall patient well-being.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for not_applicable alzheimer-disease

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable alzheimer-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2024

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

March 5, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 10, 2025

Completed
Last Updated

March 10, 2025

Status Verified

March 1, 2025

Enrollment Period

1.1 years

First QC Date

March 5, 2025

Last Update Submit

March 5, 2025

Conditions

Keywords

Alzheimer's DiseaseHolistic nursingPsychological stateCognitive functionPsychiatric symptoms

Outcome Measures

Primary Outcomes (2)

  • Change in Cognitive Function Assessed by MMSE

    The improvement in cognitive function will be measured using the Mini-Mental State Examination (MMSE) score. Cognitive changes will be evaluated pre- and post-intervention to assess the effectiveness of the Holistic Nursing intervention.

    Baseline (before intervention) and after 6 months of intervention.

  • Change in Cognitive Function Assessed by MoCA

    The improvement in cognitive function will be measured using the Montreal Cognitive Assessment (MoCA) score. Cognitive changes will be evaluated pre- and post-intervention to assess the effectiveness of the Holistic Nursing intervention.

    Baseline (before intervention) and after 6 months of intervention.

Secondary Outcomes (6)

  • Change in Psychiatric Symptoms Assessed by NPI

    Baseline (before intervention) and after 6 months of intervention.

  • Change in Anxiety Levels (SAS Score)

    Baseline (before intervention) and after 6 months of intervention.

  • Medication Adherence

    Baseline (before intervention) and after 6 months of intervention.

  • Family Satisfaction

    At discharge (approximately within 24 hours of patient discharge).

  • Change in Cognitive Function Related to Psychiatric Symptoms Assessed by ADAS-cog

    Baseline (before intervention) and after 6 months of intervention.

  • +1 more secondary outcomes

Study Arms (2)

Control Group

NO INTERVENTION

Observation Group

EXPERIMENTAL
Behavioral: Holistic Nursing

Interventions

The intervention in this study is based on Holistic Nursing (HN) for patients with Alzheimer's Disease (AD). It involves a comprehensive approach including psychological support, cognitive rehabilitation, memory enhancement, self-care training, and environmental modifications. Psychological interventions focus on personalized communication and emotional support, aiming to reduce negative emotions and improve trust in the healthcare team. Cognitive interventions include activities like painting, card recognition, and storytelling to enhance cognitive function. Memory interventions use personalized memory aids, and self-care interventions aim to improve daily living skills. The ward environment is adjusted to promote safety and comfort. This multi-faceted approach is designed to improve cognitive function, self-care abilities, and emotional well-being in AD patients.

Observation Group

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with Alzheimer's Disease (AD) according to clinical and neuroimaging evidence.
  • Aged between 60 to 80 years.
  • Mild-to-moderate disease severity, with a Mini-Mental State Examination (MMSE) score ranging from 10 to 24.
  • Adequate cognitive and functional capacity to complete questionnaires and follow the intervention protocol.
  • Ability to communicate and comprehend instructions.
  • Availability of comprehensive medical records.
  • Informed consent obtained from the patient or their legal guardian.

You may not qualify if:

  • History of intracranial surgery or major brain trauma.
  • Coexisting psychiatric disorders or severe mental illnesses.
  • Significant visual, auditory, language, or motor impairments that would hinder participation in the study.
  • Severe organ dysfunction that could interfere with study participation or safety.
  • Comorbid autoimmune diseases or severe malignancies.
  • Participants who have received experimental treatments or clinical trials within the last 3 months.
  • Pregnant or breastfeeding women.
  • Individuals with a history of substance abuse or dependency.
  • Participants with other medical conditions that, in the opinion of the investigator, would compromise participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Jinzhou Medical University

Jinzhou, Liaoning, China

Location

Related Publications (1)

  • Yu J, Zhu L, Song Y, Shi B, Zhou X. Positive Impact of Holistic Nursing on Cognitive Impairment and Psychiatric Symptoms in Patients With Alzheimer's Disease. Actas Esp Psiquiatr. 2025 May;53(3):586-597. doi: 10.62641/aep.v53i3.1948.

MeSH Terms

Conditions

Alzheimer Disease

Interventions

Holistic Nursing

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Nursing CareHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2025

First Posted

March 10, 2025

Study Start

January 1, 2023

Primary Completion

January 31, 2024

Study Completion

January 31, 2024

Last Updated

March 10, 2025

Record last verified: 2025-03

Locations